US 7241796
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K31/407A61K38/00
Quick answer
US patent 7241796 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/407, A61K38/00, A61K45/06, A61P